
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16042913
[patent_doc_number] => 10683315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereof
[patent_app_type] => utility
[patent_app_number] => 15/744094
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9937
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15744094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/744094 | Prodrug of an HCV NS5B polymerase inhibitor and method of production and application thereof | Apr 6, 2017 | Issued |
Array
(
[id] => 11821822
[patent_doc_number] => 20170210759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'ACTIVATORS OF AUTOPHAGIC FLUX AND PHOSPHOLIPASE D AND CLEARANCE OF PROTEIN AGGREGATES INCLUDING TAU AND TREATMENT OF PROTEINOPATHIES'
[patent_app_type] => utility
[patent_app_number] => 15/480220
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7961
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15480220
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/480220 | Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies | Apr 4, 2017 | Issued |
Array
(
[id] => 11757226
[patent_doc_number] => 20170204095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => '(1-AZINONE)-SUBSTITUTED PYRIDOINDOLES'
[patent_app_type] => utility
[patent_app_number] => 15/477984
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101677
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477984 | (1-AZINONE)-SUBSTITUTED PYRIDOINDOLES | Apr 2, 2017 | Abandoned |
Array
(
[id] => 11757189
[patent_doc_number] => 20170204057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'STABILIZED COMPOSITIONS AND METHODS OF MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 15/477268
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6181
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477268
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/477268 | Stabilized compositions and methods of manufacture | Apr 2, 2017 | Issued |
Array
(
[id] => 11834543
[patent_doc_number] => 20170216262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-03
[patent_title] => 'AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/473110
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54944
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15473110
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/473110 | AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES | Mar 28, 2017 | Abandoned |
Array
(
[id] => 17378079
[patent_doc_number] => 11236076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Reaction medium containing water-surfactant mixture
[patent_app_type] => utility
[patent_app_number] => 16/088374
[patent_app_country] => US
[patent_app_date] => 2017-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6300
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16088374
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/088374 | Reaction medium containing water-surfactant mixture | Mar 26, 2017 | Issued |
Array
(
[id] => 11730545
[patent_doc_number] => 20170191986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'Compounds and Method of Identifying, Synthesizing, Optimizing and Profiling Protein Modulators'
[patent_app_type] => utility
[patent_app_number] => 15/462115
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 50105
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462115 | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators | Mar 16, 2017 | Issued |
Array
(
[id] => 13814369
[patent_doc_number] => 10183945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-22
[patent_title] => Method of preparing AZA-pyridone compounds
[patent_app_type] => utility
[patent_app_number] => 15/455780
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7984
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455780 | Method of preparing AZA-pyridone compounds | Mar 9, 2017 | Issued |
Array
(
[id] => 16311280
[patent_doc_number] => 20200290018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => SUPPORTED METAL CATALYST
[patent_app_type] => utility
[patent_app_number] => 16/082080
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082080 | Supported metal catalyst | Mar 9, 2017 | Issued |
Array
(
[id] => 11713547
[patent_doc_number] => 20170182045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'Novel Phtalazinone Derivatives and Manufacturing Process Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/455631
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58680
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15455631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/455631 | Phtalazinone derivatives and manufacturing process thereof | Mar 9, 2017 | Issued |
Array
(
[id] => 15324051
[patent_doc_number] => 20200002355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => PRMT5 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/082230
[patent_app_country] => US
[patent_app_date] => 2017-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082230
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082230 | PRMT5 inhibitors | Mar 8, 2017 | Issued |
Array
(
[id] => 14962929
[patent_doc_number] => 20190308942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => SMALL MOLECULE INDUCERS OF REACTIVE OXYGEN SPECIES AND INHIBITORS OF MITOCHONDRIAL ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/083376
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22006
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083376 | Small molecule inducers of reactive oxygen species and inhibitors of mitochondrial activity | Mar 6, 2017 | Issued |
Array
(
[id] => 11971135
[patent_doc_number] => 20170275289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-28
[patent_title] => 'THERAPEUTIC COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/449692
[patent_app_country] => US
[patent_app_date] => 2017-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39447
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15449692
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/449692 | Therapeutic compounds and uses thereof | Mar 2, 2017 | Issued |
Array
(
[id] => 11690842
[patent_doc_number] => 20170166557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-15
[patent_title] => '6-SUBSTITUTED QUINAZOLINONE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/443232
[patent_app_country] => US
[patent_app_date] => 2017-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29424
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15443232
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/443232 | 6-substituted quinazolinone inhibitors | Feb 26, 2017 | Issued |
Array
(
[id] => 16991769
[patent_doc_number] => 20210230189
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
[patent_app_type] => utility
[patent_app_number] => 16/078152
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 346717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -197
[patent_words_short_claim] => 1817
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078152 | Compounds that inhibit MCL-1 protein | Feb 23, 2017 | Issued |
Array
(
[id] => 12489756
[patent_doc_number] => 09994529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Amino quinazolines as kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/431942
[patent_app_country] => US
[patent_app_date] => 2017-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25969
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431942 | Amino quinazolines as kinase inhibitors | Feb 13, 2017 | Issued |
Array
(
[id] => 11649120
[patent_doc_number] => 20170145022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'Imidazopyridazine Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/426423
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29965
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426423
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426423 | Imidazopyridazine compounds | Feb 6, 2017 | Issued |
Array
(
[id] => 11648088
[patent_doc_number] => 20170143988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 15/425473
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13738
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425473 | WATER SOLUBLE ANIONIC BACTERIOCHLOROPHYLL DERIVATIVES AND THEIR USES | Feb 5, 2017 | Abandoned |
Array
(
[id] => 11625834
[patent_doc_number] => 20170136023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'QUINAZOLINE DERIVATIVE AS TYROSINE-KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/419781
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15831
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15419781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/419781 | Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof | Jan 29, 2017 | Issued |
Array
(
[id] => 11851633
[patent_doc_number] => 20170226124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'PHTHALAZINONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/411101
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20704
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411101
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411101 | PHTHALAZINONE DERIVATIVES | Jan 19, 2017 | Abandoned |